After Rocketing Higher, Can These 3 Biotechs Continue To Soar?

A clinical-stage biotech company focused on developing tumor-specific immunotherapies to fight multiple cancer types — and which is also developing a COVID-19 vaccine that could aid in the battle against variant strains of the virus — is among the three biotechs highlighted in today’s article that have seen their stock prices soar this year – by 265% in the case of the aforementioned company. Which of these three biotech stocks may be good buys at this point? CLICK HERE.